Efficacy, once-daily convenience make drug good choice
January 15th 2006Portland, OR—The novel formulation of timolol maleate 0.5% ophthalmic solution containing potassium sorbate (Istalol, ISTA Pharmaceuticals) is a good option to consider for adjunctive therapy in patients whose IOP is not adequately controlled by a prostaglandin analogue alone, said John R. Samples, MD.
Read More
The complaint of double vision can cause confusion
January 15th 2006Chicago—Clinicians should use a systematic approach when confronted with the complaint of double vision. Knowing the possible symptoms and signs associated with diplopia can help with the diagnosis, explained Kimberly Cockerham, MD, FACS, at the neuro-ophthalmology subspecialty day meeting during the American Academy of Ophthalmology annual meeting.
Read More
High degree of suspicion needed for diagnosis of acute orbitopathies
January 1st 2006Chicago-"When is a lid laceration not just a lid laceration?" When it is occult penetrating orbito-cranial trauma, explained Roger E. Turbin, MD, assistant professor of ophthalmology and associate director of neuro-ophthalmology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School.
Read More
Favorable outcomes persist with pediatric ICL
December 1st 2005Toulouse, France—With lengthening follow-up, the posterior chamber implantable collamer lens (ICL) (STAAR Surgical) continues to be associated with encouraging results in the management of refractive amblyopia in children who have not had a response to conventional therapy with contact lenses or spectacles, said Laurence C. Lesueur, MD.
Read More
Encapsulated trabeculectomy blebs resolve in study
December 1st 2005Houston—Filtering bleb encapsulation after trabeculectomy seems to respond well to tapering topical corticosteroids alone or in conjunction with IOP-lowering agents. Withdrawing steroids appeared beneficial for lowering the IOP compared with continuing the use of steroids to prevent inflammation, according to Sheila Bazzaz, MD.
Read More
NSAIDs help control inflammation, prevent CME
November 15th 2005With cataract and refractive procedures, ocular comfort and inflammation management are highly relevant to the patient's impression of a successful procedure. Add to that an expectation that an increase in visual acuity will follow closely on the heels of surgery, and the standards are set very high.
Read More
Dose moderation key in limiting toxicity of intracameral triamcinolone
October 17th 2005Intracameral triamcinolone acetonide (Kenalog, Bristol?Myers Squibb) used judiciously offers simple and safe anti-inflammatory treatment in cataract surgery patients, said James P. Gills, MD, at "Spotlight on Cataract Surgery in 2005" during the annual meeting of the American Academy of Ophthalmology.
Read More
Diplopia may be first sign of giant cell arteritis
October 17th 2005A number of pathologies can be confused with giant cell arteritis, Anthony Arnold, MD, explained Monday at the American Academy of Ophthalmology annual meeting. Patients with a painful ophthalmoplegia might have an isolated cranial neuropathy, a skull-based or cavernous sinus process such as a tumor, or an inflammatory or infiltrative process, an orbital process, a brainstem process, or a vasculitic process.
Read More
Causes of childhood blindness changing
October 16th 2005The patterns of childhood blindness and visual impairment are changing over time, according to Clare Gilbert, MD, MSc. Dr. Gilbert described the shifts in pediatric blindness patterns resulting from the ?nurture? factors Sunday at the American Academy of Ophthalmology annual meeting.
Read More
Refractive surgery an option for kids with high bilateral myopia
October 15th 2005Orlando—Refractive surgery may be an option for treating children with high myopia and neurobehavioral disorders who are unable to use either of the two principal methods of correcting myopia, spectacles or contact lenses.
Read More
Refractec promotes Frinzi to chief operating officer
October 14th 2005Refractec Inc. announces the promotion of Thomas G. Frinzi to the newly created position of chief operating officer to oversee the company?s growing global operations. Frinzi, formerly senior vice president of sales and marketing, will add clinical, regulatory affairs, and quality assurance to his sales and marketing responsibilities. He continues to report directly to President and CEO Mitchell B. Campbell.
Read More
Dry eye a constantly changing landscape
September 1st 2005Washington, DC-Dry eye disease affects millions of people worldwide and with that has come a recent greater awareness among patients that it is indeed a problem. As the recognition of the magnitude of dry eye is changing, so too has knowledge of its pathogenesis, the technology facilitating diagnosis, and the drugs that are becoming available to treat it. General ophthalmologists will be increasingly challenged to learn more about the disease and the best ways to treat individual patients, according to Michael Lemp, MD.
Read More
High-frequency UBM helpful tool in strabismus reoperation
September 1st 2005Orlando—The high-frequency ultrasound biomicroscope (UBM) can reliably estimate the distance of horizontal muscle insertion from the limbus in eyes that had previous strabismus surgery on the same muscle, according to Shuan H. Dai, MB, BS, FRANZCO, a pediatric ophthalmologist.
Read More
AAPOS backs pediatric screening
July 15th 2005Orlando—Ongoing efforts to encourage the adoption of mandatory preschool vision screening in every state were the main topic of discussion during a workshop at the annual meeting of the American Academy of Pediatric Ophthalmology and Strabismus (AAPOS).
Read More